Remission Status at Transplantation and Treatment History Determine the Survival Chances of Patients after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia Who Had Received Pre-Treatment with Idelalisib: A Report from the EBMT Chronic Malignancies Working Party

Schetelig, Johannes; Md, ; Chevallier, Patrice; Md, ; Van Gelder, Michel; Phd, Md; Hoek, Jennifer; Hermine, Olivier; Chakraverty, Ronjon; Phd, Bmbs; Browne, Paul; Md, ; Milpied, Noel; Malagola, Michele; Md, ; Socie, Gerard; Phd, Md; Delgado, Julio; Md, ; Deconinck, Eric; Phd, Md; Damaj, Gandhi; Md, ; Cordonnier, Catherine; Md, ; W Beelen, Dietrich; Phd, Md; Nguyen, Stephanie; Phd, Md; Nikolousis, Emmanouil; Brecht, Arne; Md, ; Mayer, Jiri; Prof, ; Scs, Md; Hunault, Mathilde; Phd, Md; Thomas Bittenbring, Jörg; Md, ; Thieblemont, Catherine; Phd, Md; Leprêtre, Stéphane; Md, ; C de Wreede, Liesbeth; Tabellini, Giovanna; Dreger, Peter; Md, ; Kröger, Nicolaus